LifeStance Health Group (NASDAQ:LFST) Now Covered by KeyCorp

Stock analysts at KeyCorp began coverage on shares of LifeStance Health Group (NASDAQ:LFST - Get Free Report) in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage set an "overweight" rating and a $9.00 price target on the stock. KeyCorp's price objective would suggest a potential upside of 31.58% from the stock's previous close.

LFST has been the subject of several other reports. Canaccord Genuity Group started coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They issued a "buy" rating and a $8.00 target price for the company. William Blair reissued an "outperform" rating on shares of LifeStance Health Group in a research note on Friday, February 28th. Finally, The Goldman Sachs Group upgraded LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price objective for the company in a report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $8.58.

LifeStance Health Group Trading Up 1.0 %

Shares of LifeStance Health Group stock traded up $0.07 on Tuesday, reaching $6.84. 1,837,012 shares of the company's stock were exchanged, compared to its average volume of 1,608,433. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The company has a market capitalization of $2.63 billion, a P/E ratio of -26.31 and a beta of 1.30. The firm's 50-day moving average is $7.28 and its two-hundred day moving average is $7.33. LifeStance Health Group has a 52 week low of $4.64 and a 52 week high of $8.61.

Remove Ads

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the transaction, the insider now directly owns 339,810 shares of the company's stock, valued at $2,344,689. The trade was a 5.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 6.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. Charles Schwab Investment Management Inc. increased its stake in LifeStance Health Group by 36.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company's stock valued at $7,731,000 after buying an additional 297,723 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in LifeStance Health Group by 10.5% during the third quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company's stock worth $572,000 after acquiring an additional 7,798 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of LifeStance Health Group by 31.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company's stock valued at $169,000 after purchasing an additional 5,767 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in LifeStance Health Group by 10.4% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 516,819 shares of the company's stock worth $3,618,000 after buying an additional 48,634 shares during the last quarter. Finally, Quadrature Capital Ltd purchased a new position in LifeStance Health Group in the third quarter valued at about $341,000. 85.50% of the stock is owned by institutional investors.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.